MORGAN STANLEY - VIRPAX PHARMACEUTICALS INC ownership

VIRPAX PHARMACEUTICALS INC's ticker is VRPX and the CUSIP is 928251107. A total of 16 filers reported holding VIRPAX PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of VIRPAX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$120
-25.9%
1500.0%0.00%
Q2 2023$162
+37.3%
1500.0%0.00%
Q1 2023$118
-82.4%
150
-86.1%
0.00%
Q4 2022$669
-33.1%
1,076
+0.9%
0.00%
Q3 2022$1,000
-96.7%
1,066
-94.1%
0.00%
Q2 2022$30,000
-82.8%
18,016
-77.1%
0.00%
Q1 2022$174,000
+987.5%
78,511
+1504.9%
0.00%
Q4 2021$16,000
+45.5%
4,892
+119.9%
0.00%
Q3 2021$11,000
+266.7%
2,225
+210.8%
0.00%
Q2 2021$3,0007160.00%
Other shareholders
VIRPAX PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 701,455$550,6420.48%
Quantum Private Wealth, LLC 10,000$7,8500.00%
Warberg Asset Management LLC 17,012$13,3540.00%
Belpointe Asset Management LLC 19,045$14,9500.00%
OSAIC HOLDINGS, INC. 600$4710.00%
PNC FINANCIAL SERVICES GROUP, INC. 100,875$79,1870.00%
WELLS FARGO & COMPANY/MN 60$470.00%
NORTHERN TRUST CORP 15,221$11,9480.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 66,038$51,6080.00%
View complete list of VIRPAX PHARMACEUTICALS INC shareholders